[
  {
    "ts": null,
    "headline": "Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know",
    "summary": "Caribou Biosciences (CRBU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=fef8d12b0dd6edd3e100374a7122215ebe56ef818b419bd5be12ceba734df09a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745935284,
      "headline": "Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know",
      "id": 134131139,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Caribou Biosciences (CRBU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=fef8d12b0dd6edd3e100374a7122215ebe56ef818b419bd5be12ceba734df09a"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 375-point rally led by gains for Sherwin-Williams Co., Honeywell shares",
    "summary": "Dow's 375-point rally led by gains for Sherwin-Williams Co., Honeywell shares",
    "url": "https://finnhub.io/api/news?id=9a11fd64c292d36c252da572c892f93c1e7821d789a9f8a656c7666949da282d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745935020,
      "headline": "Dow's 375-point rally led by gains for Sherwin-Williams Co., Honeywell shares",
      "id": 134147645,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow's 375-point rally led by gains for Sherwin-Williams Co., Honeywell shares",
      "url": "https://finnhub.io/api/news?id=9a11fd64c292d36c252da572c892f93c1e7821d789a9f8a656c7666949da282d"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 125-point rally led by gains for Sherwin-Williams Co., Honeywell stocks",
    "summary": "Dow's 125-point rally led by gains for Sherwin-Williams Co., Honeywell stocks",
    "url": "https://finnhub.io/api/news?id=c84979852f70a4fcc0e21c653a2596b97d4ea6efe8d9d79b46c816243fb33b75",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745931360,
      "headline": "Dow's 125-point rally led by gains for Sherwin-Williams Co., Honeywell stocks",
      "id": 134147510,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow's 125-point rally led by gains for Sherwin-Williams Co., Honeywell stocks",
      "url": "https://finnhub.io/api/news?id=c84979852f70a4fcc0e21c653a2596b97d4ea6efe8d9d79b46c816243fb33b75"
    }
  },
  {
    "ts": null,
    "headline": "Can Amgen Keep the Beat Streak Alive This Earnings Season?",
    "summary": "Volume growth of AMGN's key drugs like Evenity, Repatha and Kyprolis is expected to have been partially offset by biosimilar/generic competition for mature drugs.",
    "url": "https://finnhub.io/api/news?id=6fbebc2067e1a699b49a73314d8c402cae4b3107eaf0f4a5f9402d3ca5493f1a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745923320,
      "headline": "Can Amgen Keep the Beat Streak Alive This Earnings Season?",
      "id": 134131140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Volume growth of AMGN's key drugs like Evenity, Repatha and Kyprolis is expected to have been partially offset by biosimilar/generic competition for mature drugs.",
      "url": "https://finnhub.io/api/news?id=6fbebc2067e1a699b49a73314d8c402cae4b3107eaf0f4a5f9402d3ca5493f1a"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron",
    "summary": "Pfizer, Eli Lilly, Amgen, Biogen and Regeneron are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=b533d00f3cfcfab75996e6f61bdb4111f0bc92aa9dbf9d909f8cdf7ce7accfce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745922720,
      "headline": "The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron",
      "id": 134130902,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Pfizer, Eli Lilly, Amgen, Biogen and Regeneron are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=b533d00f3cfcfab75996e6f61bdb4111f0bc92aa9dbf9d909f8cdf7ce7accfce"
    }
  }
]